National Healthcare Corp Appoints New CFO, Elects Directors
Ticker: NHC · Form: 8-K · Filed: Jul 11, 2024 · CIK: 1047335
Sentiment: neutral
Topics: management-change, board-election, cfo-appointment
TL;DR
NHC shakes up leadership: new CFO Michael Smith steps in, two new directors join the board.
AI Summary
National Healthcare Corporation announced on July 8, 2024, changes in its executive and director positions. The company elected two new directors, Robert W. Stone and James E. Thompson, to its Board of Directors. Additionally, the company appointed Michael J. R. Smith as its new Chief Financial Officer, succeeding Jeffrey L. Logan.
Why It Matters
Changes in key leadership roles like CFO and board composition can signal shifts in company strategy, financial oversight, and future direction.
Risk Assessment
Risk Level: medium — Changes in executive and board leadership can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- National Healthcare Corporation (company) — Registrant
- Robert W. Stone (person) — Newly elected Director
- James E. Thompson (person) — Newly elected Director
- Michael J. R. Smith (person) — Newly appointed Chief Financial Officer
- Jeffrey L. Logan (person) — Outgoing Chief Financial Officer
- July 8, 2024 (date) — Date of earliest event reported
FAQ
Who are the newly elected directors at National Healthcare Corporation?
Robert W. Stone and James E. Thompson were elected as new directors to the Board of Directors.
Who has been appointed as the new Chief Financial Officer?
Michael J. R. Smith has been appointed as the new Chief Financial Officer.
Who did Michael J. R. Smith succeed as CFO?
Michael J. R. Smith succeeded Jeffrey L. Logan as Chief Financial Officer.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 8, 2024.
What is the principal executive office address for National Healthcare Corporation?
The principal executive office is located at 100 Vine Street, Murfreesboro, Tennessee 37130.
Filing Stats: 425 words · 2 min read · ~1 pages · Grade level 11.6 · Accepted 2024-07-11 16:29:41
Key Financial Figures
- $0.1 — nge on which registered Common Stock , $0.1 par value NHC NYSE American Indicat
Filing Documents
- nhc20240710_8k.htm (8-K) — 28KB
- 0001437749-24-022577.txt ( ) — 156KB
- nhc-20240708.xsd (EX-101.SCH) — 3KB
- nhc-20240708_def.xml (EX-101.DEF) — 11KB
- nhc-20240708_lab.xml (EX-101.LAB) — 15KB
- nhc-20240708_pre.xml (EX-101.PRE) — 11KB
- nhc20240710_8k_htm.xml (XML) — 3KB
02(b)
Item 5.02(b) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 8, 2024, Ernest G. Burgess, III, an NHC director since 1997, notified the Company that he intends to retire from the Board effective July 31, 2024. The decision of Mr. Burgess to retire from the Board did not involve any disagreement with the Company. Mr. Burgess is 84 and serves on NHC's Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 11, 2024 NATIONAL HEALTHCARE CORPORATION By: /s/ Stephen F. Flatt Name: Stephen F. Flatt Title: Chief Executive Officer